NasdaqCM - Nasdaq Real Time Price USD
Entero Therapeutics, Inc. (ENTO)
At close: November 22 at 4:00 PM EST
After hours: November 22 at 6:51 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -0.41 | 0 | -1.13 | -1.52 |
| Low Estimate | -0.41 | 0 | -1.13 | -1.52 |
| High Estimate | -0.41 | 0 | -1.13 | -1.52 |
| Year Ago EPS | -44.71 | -- | -47.88 | -1.13 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | -- | 0.00% | 0.00% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -4.03 | -2.43 | -1.55 | -0.32 |
| EPS Actual | -44.71 | 0.38 | -3.37 | -0.43 |
| Difference | -40.68 | 2.81 | -1.82 | -0.11 |
| Surprise % | -1,008.05% | 115.64% | -117.19% | -35.91% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.41 | 0 | -1.13 | -1.52 |
| 7 Days Ago | -0.43 | 0 | -1.8 | -1.55 |
| 30 Days Ago | -0.43 | 0 | -1.8 | -1.55 |
| 60 Days Ago | -0.69 | 0 | -3.59 | -1.27 |
| 90 Days Ago | -1 | 0 | -5.6 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | 1 | 1 |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ENTO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 99.08% | -- | -- | 5.00% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | 97.64% | -- | -- | 2.10% |
| Next Year | -34.51% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Roth MKM: Buy to Buy | 3/15/2024 |
| Maintains | Roth MKM: Buy to Buy | 1/3/2024 |
Related Tickers
KLTO Klotho Neurosciences, Inc.
0.3510
-4.70%
REVB Revelation Biosciences, Inc.
0.7550
+0.27%
AZTR Azitra, Inc.
0.4720
+0.43%
QNRX Quoin Pharmaceuticals, Ltd.
0.5850
-6.43%
SLRX Salarius Pharmaceuticals, Inc.
1.3700
-6.16%
CELU Celularity Inc.
2.7600
-3.16%
PBLA Panbela Therapeutics, Inc.
0.3488
+8.76%
GYRE Gyre Therapeutics, Inc.
11.29
-3.91%
PXMD PaxMedica, Inc.
0.0995
+42.14%
EFTR eFFECTOR Therapeutics, Inc.
0.0002
0.00%